posted on 2023-06-08, 19:42authored byGlaxo Group Limited, Brian Cox, Suzanne Elaine Keeling, David George Allen, Alison Judith Redgrave, Michael David Barker, Heather Hobbs, Thomas Davis IV Roper, Joanna Victoria Geden
Preparation of 2-(purin-9-yl)-tetrahydrofuran-3,4-diol nucleosides as antiinflammatory agents and agonists against adenosine receptors.